Indications and limitations of vismodegib for basal cell carcinoma

JAMA Ophthalmol. 2014 Jul;132(7):905-6. doi: 10.1001/jamaophthalmol.2014.1787.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anilides / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Basal Cell / drug therapy*
  • Eyelid Neoplasms / drug therapy*
  • Female
  • Humans
  • Male
  • Orbital Neoplasms / drug therapy*
  • Pyridines / therapeutic use*
  • Skin Neoplasms / drug therapy*

Substances

  • Anilides
  • Antineoplastic Agents
  • Pyridines